STERIS (NYSE:STE) CEO Daniel Carestio Sells 1,374 Shares

STERIS plc (NYSE:STE) CEO Daniel Carestio sold 1,374 shares of the company’s stock in a transaction that occurred on Friday, June 5th. The shares were sold at an average price of $212.00, for a total transaction of $291,288.00. Following the transaction, the chief executive officer owned 63,647 shares in the company, valued at $13,493,164. The trade was a 2.11% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

STERIS Trading Down 1.0%

Shares of STERIS stock opened at $210.19 on Tuesday. The firm has a market capitalization of $20.52 billion, a price-to-earnings ratio of 26.51 and a beta of 0.93. STERIS plc has a 12-month low of $195.14 and a 12-month high of $269.44. The firm’s 50 day simple moving average is $216.98 and its two-hundred day simple moving average is $238.63. The company has a current ratio of 2.09, a quick ratio of 1.54 and a debt-to-equity ratio of 0.25.

STERIS (NYSE:STE) last released its quarterly earnings data on Monday, May 11th. The medical equipment provider reported $2.83 earnings per share for the quarter, missing analysts’ consensus estimates of $2.86 by ($0.03). The business had revenue of $1.59 billion during the quarter, compared to analyst estimates of $1.59 billion. STERIS had a return on equity of 14.15% and a net margin of 13.18%.The firm’s revenue was up 6.7% compared to the same quarter last year. During the same quarter in the previous year, the company earned $2.74 EPS. STERIS has set its FY 2027 guidance at 11.100-11.300 EPS. Analysts predict that STERIS plc will post 11.18 EPS for the current year.

STERIS Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, June 26th. Stockholders of record on Monday, June 8th will be paid a $0.63 dividend. The ex-dividend date is Monday, June 8th. This represents a $2.52 dividend on an annualized basis and a dividend yield of 1.2%. STERIS’s dividend payout ratio is presently 31.78%.

Analysts Set New Price Targets

A number of analysts have recently weighed in on the stock. Wall Street Zen lowered shares of STERIS from a “strong-buy” rating to a “buy” rating in a research note on Saturday. Piper Sandler restated an “overweight” rating and issued a $270.00 price objective on shares of STERIS in a research report on Thursday, May 21st. KeyCorp lowered their price objective on STERIS from $291.00 to $269.00 and set an “overweight” rating on the stock in a research report on Wednesday, May 13th. Finally, Weiss Ratings lowered shares of STERIS from a “hold (c+)” rating to a “hold (c)” rating in a report on Wednesday, May 27th. Three equities research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $278.00.

Institutional Trading of STERIS

Several hedge funds and other institutional investors have recently added to or reduced their stakes in STE. Nordea Investment Management AB lifted its stake in shares of STERIS by 259.0% in the fourth quarter. Nordea Investment Management AB now owns 51,602 shares of the medical equipment provider’s stock worth $13,165,000 after buying an additional 37,228 shares in the last quarter. Dimensional Fund Advisors LP lifted its stake in shares of STERIS by 9.4% in the third quarter. Dimensional Fund Advisors LP now owns 1,039,351 shares of the medical equipment provider’s stock worth $257,157,000 after buying an additional 89,250 shares in the last quarter. Legal & General Group Plc lifted its stake in shares of STERIS by 5.3% in the third quarter. Legal & General Group Plc now owns 693,116 shares of the medical equipment provider’s stock worth $171,505,000 after buying an additional 34,981 shares in the last quarter. Elo Mutual Pension Insurance Co purchased a new position in shares of STERIS in the third quarter worth about $2,480,000. Finally, Groupama Asset Managment purchased a new position in shares of STERIS in the third quarter worth about $1,163,000. Institutional investors and hedge funds own 94.69% of the company’s stock.

STERIS Company Profile

STERIS Corporation (NYSE: STE) is a global provider of infection prevention, contamination control and procedural products and services for the healthcare, life sciences, pharmaceutical and medical device industries. The company develops, manufactures and supports a broad portfolio of equipment and consumables designed to reduce risk of infection, maintain sterile environments and support critical clinical and manufacturing procedures.

Its offerings include sterilization and decontamination systems, instrument washers and washers-disinfectors, endoscope reprocessing solutions, surgical equipment and procedural disposables, and contamination-control products for cleanrooms and laboratories.